News - Cell Therapeutics, Financial

Filter

Popular Filters

Cell Therapeutics changes name to CTI BioPharma

Cell Therapeutics changes name to CTI BioPharma

30-05-2014

US biotech firm Cell Therapeutics Inc says it will change its corporate name to CTI BioPharma Corp effective…

BiotechnologyCell TherapeuticsFinancial

Cell Therapeutics sees 2013 revenue rise thanks to Baxter deal

05-03-2014

US biotech firm Cell Therapeutics (Nasdaq: CTIC) revenue soared last year to $34.7 million, due to a…

BiotechnologyCell TherapeuticsFinancialpacritinibUSA

Baxter buys exclusive rights to CTI’s cancer drug pacritinib

18-11-2013

USA-based companies Baxter International and Cell Therapeutics have entered into an exclusive worldwide…

Baxter InternationalCell TherapeuticsFinancialGlobalLicensingOncologypacritinibPharmaceutical

Cell Therapeutics prepares for Pixuvri launch; posts 2nd-qtr results

01-08-2012

US biotech firm Cell Therapeutics (Nasdaq: CTIC) yesterday reported second-quarter 2012 financial results…

BiotechnologyCell TherapeuticsFinancialMarkets & MarketingOncologypacritinibPixuvriRare diseasesResearchtosedostat

Back to top